Chiropractors in Orem, UT Accepting Medicare
87 Chiropractors found. Showing 81 - 87
 Dr. Jason David Reese, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1160 S State St, Suite 180a, Orem, UT 84097 Phone: 801-226-0932 Fax: 801-226-0933 |
 Aznar, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 555 S State St, Suite 203, Orem, UT 84058 Phone: 801-221-7012 |
Tveten Chiropractic Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 825 E 800 N, Orem, UT 84097 Phone: 385-254-5552 |
Dr. Skylar D. Weeks, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 230 S Ridgeview Dr, Orem, UT 84058 Phone: 570-523-3444 |
Sound Corrections Chiropractic, Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 251 E 1200 S, Orem, UT 84058 Phone: 801-900-3223 Fax: 385-375-3718 |
Dr. John G. Aznar, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 555 S State St, Suite 203, Orem, UT 84058 Phone: 801-221-7012 |
Flat Rate Doctors Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 218 E 800 S, Orem, UT 84058 Phone: 801-610-7283 |
News Archive
ADAO applauds U.S. Senate for introduction of resolution recognizing National Asbestos Awareness Week
The Asbestos Disease Awareness Organization, combining education, advocacy and community as the largest U.S. organization serving as the voice of asbestos victims, today applauds Senator Max Baucus and cosponsors for introducing a resolution that declares the first week of April as "National Asbestos Awareness Week" and seeks to "raise public awareness about the prevalence of asbestos-related diseases and the dangers of asbestos exposure."
Study explores effects of patent foramen ovale in high-altitude Bolivian setting
A common heart feature long thought to have negligible effects on human health and performance may be problematic at high altitude, according to University of Oregon researchers.
DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.
Industry sponsored drug and device studies: an interview with Professor Lisa Bero
Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.
South Korean group delivers food aid to North Korea
The Korean Sharing Movement, a South Korean relief group, "crossed into North Korea Tuesday with 12 trucks full of flour, marking the first food aid of its kind since a North Korean attack last year," VOA's "Breaking News" blog reports.
› Verified 2 days ago
Chiropractors
Physical Therapists
Optometrists
Speech-Language Pathologists
Occupational Therapists
Podiatrists
Audiologists